Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Timolol Maleate Gel in Healthy Chinese Adults
NCT06824948Phase 1Completed
- Sponsor
- Auson Pharmaceuticals
- Start
- Oct 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of timolol maleate gel + placebo in infantile hemangioma (IH) (3 arms), sponsored by Auson Pharmaceuticals. Primary endpoints: Local tolerance at Day 13, Adverse events at Day 13 and 6 more. Started Oct 2018; status: completed.
02
Drugs
timolol maleate gel + placebo
03
Conditions
infantile hemangioma (IH)
Beyond the preview
Go deeper on NCT06824948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06824948.